quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·14h
PRRelease
Bristol-Myers Squibb Company logo
Atrium Therapeutics Inc. logo

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

BMY· Bristol-Myers Squibb CompanyRNA· Atrium Therapeutics Inc.
Health Care
Original source

Companies

  • BMY
    Bristol-Myers Squibb Company
    Health Care
  • RNA
    Atrium Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Mar 11RNAUpdateWells Fargo$25.00
  • Feb 25BMYUpdateRBC Capital Mkts$60.00
  • Feb 20BMYUpdateBarclays$75.00
  • Jan 7BMYUpdateUBS$65.00
  • Dec 15BMYUpdateBofA Securities$61.00
  • Dec 12BMYUpdateGuggenheim$62.00

Related

  • INSIDER1d
    SEC Form 4 filed by Kenney Stephanie
  • INSIDER1d
    SEC Form 4 filed by Hughes Steven George
  • INSIDER1d
    SEC Form 4 filed by Winslow Brendan R.
  • INSIDER1d
    SEC Form 4 filed by Gallagher Kathleen P.
  • INSIDER1d
    SEC Form 4 filed by Hoyos Rocio Martin
  • INSIDER1d
    SEC Form 4 filed by Younis Husam
  • PR2d
    Foundation Medicine Expands Existing Collaboration with Bristol Myers Squibb to Develop a Next-Generation Sequencing Companion Diagnostic to Identify Patients with Homozygous MTAP Deletion
  • PR2d
    Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022